Changes in the appearance of the liquid can indicate that the medication has been exposed to extreme temperatures or has otherwise degraded
Additionally, because many people with diabetes or who are overweight may control their condition with diet, other medications and therapies, or choose to not seek treatment, not all people who meet these clinical criteria would use GLP-1 drugs
LLY also announced in mid-February 2024 that a phase 2 trial evaluating tirzepatide for liver disease metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic steatohepatitis (NASH), met its primary endpoint where up to 74% of participants achieved resolution of MASH with no worsening of fibrosis, compared to 13% on placebo
The previous contract expired April 1
The basis of semaglutide's functionality lies in its resemblance to the native human GLP-1 hormone
The evaluation of these providers can determine the effectiveness of Saxenda injections